Found: 22
Select item for more details and to access through your institution.
Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Editorial: Methods and application in cardiovascular and smooth muscle pharmacology: 2021.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1049022
- By:
- Publication type:
- Article
VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
- Published in:
- Journal of Neuroscience, 2023, v. 43, n. 23, p. 4365, doi. 10.1523/JNEUROSCI.0014-23.2023
- By:
- Publication type:
- Article
VGLUT3 Ablation Differentially Modulates Glutamate Receptor Densities in Mouse Brain.
- Published in:
- eNeuro, 2022, v. 9, n. 3, p. 1, doi. 10.1523/ENEURO.0041-22.2022
- By:
- Publication type:
- Article
mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease.
- Published in:
- Science Signaling, 2017, v. 10, n. 510, p. 1, doi. 10.1126/scisignal.aan6387
- By:
- Publication type:
- Article
mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease.
- Published in:
- Molecular Brain, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13041-020-00657-7
- By:
- Publication type:
- Article
Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice.
- Published in:
- Molecular Brain, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13041-019-0456-1
- By:
- Publication type:
- Article
Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models.
- Published in:
- Molecular Brain, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13041-018-0364-9
- By:
- Publication type:
- Article
Abnormal myosin phosphatase targeting subunit 1 phosphorylation and actin polymerization contribute to impaired myogenic regulation of cerebral arterial diameter in the type 2 diabetic Goto-Kakizaki rat.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2017, v. 37, n. 1, p. 227, doi. 10.1177/0271678X15622463
- By:
- Publication type:
- Article
Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.
- Published in:
- Frontiers in Molecular Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnmol.2022.801757
- By:
- Publication type:
- Article
Editorial: Emerging insights in glutamate receptor signaling in psychiatric, neurodevelopmental, and neurodegenerative diseases.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2024.1388514
- By:
- Publication type:
- Article
A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1769, doi. 10.1111/bph.15750
- By:
- Publication type:
- Article
Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.
- Published in:
- Science Signaling, 2020, v. 13, n. 662, p. 1, doi. 10.1126/scisignal.abd2494
- By:
- Publication type:
- Article
Abnormal Rho-associated kinase activity contributes to the dysfunctional myogenic response of cerebral arteries in type 2 diabetes<sup>1</sup>.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2015, v. 93, n. 3, p. 177, doi. 10.1139/cjpp-2014-0437
- By:
- Publication type:
- Article
Stromatoxin-sensitive, heteromultimeric Kv2.1/Kv9.3 channels contribute to myogenic control of cerebral arterial diameter X. Z. Zhong and others Heteromultimeric Kv2.1/Kv9.3 channels and cerebral myogenic response.
- Published in:
- Journal of Physiology, 2010, v. 588, n. 22, p. 4519, doi. 10.1113/jphysiol.2010.196618
- By:
- Publication type:
- Article
ROK and Arteriolar Myogenic Tone Generation: Molecular Evidence in Health and Disease.
- Published in:
- Frontiers in Pharmacology, 2017, v. 8, p. 1, doi. 10.3389/fphar.2017.00087
- By:
- Publication type:
- Article
The pleiotropic effects of antithrombotic drugs in the metabolic-cardiovascular-neurodegenerative disease continuum: impact beyond reduced clotting.
- Published in:
- Clinical Science, 2021, v. 135, n. 8, p. 1015, doi. 10.1042/CS20201445
- By:
- Publication type:
- Article
GRK2 knockdown in mice exacerbates kidney injury and alters renal mechanisms of blood pressure regulation.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-29876-8
- By:
- Publication type:
- Article
Sexual dimorphism of G prote-incoupled receptor signaling in the brain.
- Published in:
- Neural Regeneration Research, 2024, v. 19, n. 8, p. 1635, doi. 10.4103/1673-5374.389637
- By:
- Publication type:
- Article
mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease.
- Published in:
- Molecular Neurobiology, 2020, v. 57, n. 3, p. 1418, doi. 10.1007/s12035-019-01818-z
- By:
- Publication type:
- Article
Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.
- Published in:
- Molecular Brain, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13041-023-01054-6
- By:
- Publication type:
- Article
Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.
- Published in:
- Molecular Brain, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13041-023-01054-6
- By:
- Publication type:
- Article